FREM2 and central nervous system cancer: Likewise, we explored how FREM2 gene expression and pathway activation can discriminate glioma molecular subtypes LGm1-6 which are described in Ceccarelli M. et al. [19] and strongly associated with the DNA methylation-based classification of gliomas [46].